| Dennis Dicampli, MD | |
|
100 Wason Ave, Suite 200, Springfield, MA 01107-1381 | |
| (413) 733-9666 | |
| (413) 750-3432 |
| Full Name | Dennis Dicampli |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 28 Years |
| Location | 100 Wason Ave, Springfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215034723 | NPI | - | NPPES |
| 2136511 | Medicaid | MA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Medical Center | Springfield, MA | Hospital |
| Holyoke Medical Center | Holyoke, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Renal And Transplant Associates Of New England Pc | 3678898137 | 7 |
News Archive
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Breast-conserving therapy is a viable treatment option for African-American women, although they tend to have more advanced breast cancer at diagnosis, according to researchers from Beaumont Hospitals, Royal Oak, Mich. The study is available online now and will be in the July 15 issue of the journal Cancer.
Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.
A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.
› Verified 8 days ago
| Entity Name | Renal And Transplant Associates Of New England Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235535204 PECOS PAC ID: 3678898137 Enrollment ID: O20150205000066 |
News Archive
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Breast-conserving therapy is a viable treatment option for African-American women, although they tend to have more advanced breast cancer at diagnosis, according to researchers from Beaumont Hospitals, Royal Oak, Mich. The study is available online now and will be in the July 15 issue of the journal Cancer.
Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.
A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Dicampli, MD 100 Wason Ave, Ste 200, Springfield, MA 01107-1179 Ph: (413) 733-9666 | Dennis Dicampli, MD 100 Wason Ave, Suite 200, Springfield, MA 01107-1381 Ph: (413) 733-9666 |
News Archive
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Breast-conserving therapy is a viable treatment option for African-American women, although they tend to have more advanced breast cancer at diagnosis, according to researchers from Beaumont Hospitals, Royal Oak, Mich. The study is available online now and will be in the July 15 issue of the journal Cancer.
Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.
A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.
› Verified 8 days ago
Grace Makari-judson, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3350 Main Street, Springfield, MA 01107 Phone: 413-794-9338 Fax: 413-794-9754 | |
Peter Whittredge, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2 Medical Center Dr, Suite 410, Springfield, MA 01107 Phone: 413-781-5735 Fax: 413-732-0225 | |
Dr. Marc A Goldman, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 175 Carew St Ste 200, Springfield, MA 01104 Phone: 413-732-4269 Fax: 413-785-4619 | |
Twara K Tarasaria, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 759 Chestnut St, Springfield, MA 01107 Phone: 413-794-6297 Fax: 413-794-1767 | |
Dr. Joan Wanda Lisak, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 780 Chestnut St, Suite 20, Springfield, MA 01107 Phone: 413-781-2200 Fax: 413-781-2202 | |
Dr. Eva Karacsonyi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2150 Main Street, Springfield, MA 01104 Phone: 413-739-5676 Fax: 413-739-2278 | |
Dr. Sun Tien Lin, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 125 Liberty St, Suite 204, Springfield, MA 01103 Phone: 413-788-4321 Fax: 413-788-8877 |